# Weihai Disu Pharmaceutical Co., Ltd. – FDA Inspection, Apr 28, 2017

Source: https://www.keypedia.com/records/fda_inspections/weihai-disu-pharmaceutical-co-ltd/5052fe7a-5aa3-4366-849c-a82bdb2943b2
Source feed: FDA_Inspections

> FDA inspection 1017665 of Weihai Disu Pharmaceutical Co., Ltd., April 28, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1017665
- Company Name: Weihai Disu Pharmaceutical Co., Ltd.
- Inspection Date: 2017-04-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/liming-zhang/6c93b721-8725-4d87-8a42-254f3de5e49d)

Company: https://www.keypedia.com/companies/weihai-disu-pharmaceutical-co-ltd/f64aee8c-7269-4f1a-ab9c-7bd7ca4eec8b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c